Anixa biosciences featured in breaking cancer news article on novel car-t therapy for ovarian cancer

San jose, calif. , feb. 24, 2025 /prnewswire/ -- anixa biosciences, inc. ("anixa" or the "company") (nasdaq: anix), a biotechnology company focused on the treatment and prevention of cancer, today is pleased to announce that its pioneering car-t therapy for ovarian cancer, developed in collaboration with moffitt cancer center ("moffitt"), was prominently featured in breaking cancer news in an article titled "navigating uncharted territory: car-t for ovarian cancer.
CAR Ratings Summary
CAR Quant Ranking